Redhill Biopharma Ltd NASDAQ NMS - GLOBAL MARKET:RDHL
The leadership team, board of directors, and 10% beneficial owners of Redhill Biopharma Ltd, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Ben-Asher Dror
—441,350,000 sharesCabilly Shmuel
—105,200,000 sharesFrish Adi
—276,810,000 sharesGoldberg Guy Joel
—305,720,000 sharesIngber Razi
—277,560,000 sharesMamluk Roni
—103,500,000 sharesRaday Gilead
—307,580,000 sharesReed Kenneth
—105,200,000 sharesScruggs Rick D
—312,500,000 sharesTsimchi Ofer
—146,250,000 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.